Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of October 12th – 18th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
10. Field Trip Health Goes Public, Discovers New Psilocybin Molecule
Field Trip Commenced Trading Last Week on the Canadian Securities Exchange (CSE) Under the Ticker Symbol ‘FTRP’
It’s official: Psychedelics provider and mental wellness company, Field Trip Health FTRPF, is now officially a publicly-traded company, joining the growing list of Psychedelic Stocks.
9. Why Are Athletes Penalized for Using Cannabis?
Cannabis-Based Drug Testing is an Inhumane Process
Having to turn over bodily fluid to a stranger, including urine or blood, can be an invasive, humiliating experience. Most international sports competition leagues and/or regulatory bodies subject athletic competitors to various types of drug testing and it almost always includes cannabis.
READ FULL CANNABIS SPORTS ARTICLE
8. Study Finds MDMA More Cost-Effective Than Traditional PTSD Treatments
“MDMA-Assisted Psychotherapy is Conducted By a Licensed Psychologist and Trained Clinician Over the Course of 12 Sessions with Three Sessions Lasting Six or More Hours”
MDMA-assisted psychotherapy would result in significantly more cost-effective than currently available treatment options for post-traumatic stress disorder (PTSD), according to a study distributed by the Multidisciplinary Association for Psychedelic Studies (MAPS).
7. Amazon Begins Selling CBD Products Within the United Kingdom
The Pilot Program is Being Held for UK Customers Only, with Only a Select Number of Retailers
Amazon.com, Inc. AMZN has entered the global CBD market. It was reported earlier this week by BusinessCann that the giant online retailer has begun selling CBD products, but only on a trial basis, with the retailer referring to it as a pilot program.
6. Watch the Oregon Drug Decriminalization Campaign’s New TV Ads for Historic Ballot Measure
The Ads Featuring People From a Diversity of Backgrounds Speaking to Their Personal Experiences with the Drugs and the Criminal Justice System, Come as Mail-in Ballots Are Being Distributed to Registered Voters
The Oregon campaign behind a ballot initiative to decriminalize drug possession and expanding funding for substance misuse treatment is rolling out a series of TV and online ads promoting the measure.
READ FULL OREGON CAMPAIGN ARTICLE
5. Top Analyst Initiates Coverage on RWB, Issues Bullish Price Target 323% Above Market
The Driving Force Behind the Analyst’s Investment Thesis is RWB’s Dominant Position in the Rapidly Growing Michigan Marijuana Market
PI Financial analyst Jason Zandberg, who is bullish on Michigan, believes “RWB is the best vehicle to invest in the Michigan Cannabis market.” The analyst issued Red White & Bloom RWBYF a “Buy” rating and slapped a hefty $2.50 price target on RWB stock.
4. You Are Not Alone: Psychedelic Therapy and Mental Health Awareness
With Global Mental Health Awareness Day Upon Us, it’s a Good Time to Pause and Reflect on Our Wellbeing as a Species
Psychedelic medicine is poised to be the much-needed solution to the dire mental health issues, such as depression, addiction and suicide, which are plaguing millions around the globe.
READ FULL PSYCHEDELICS MENTAL HEALTH ARTICLE
3. Mexican Senate Will Vote on Marijuana Legalization Bill By End of October, Majority Leader Says
Activists Have Been Eagerly Awaiting Action on the Reform Legislation Since the Supreme Court Deemed Personal Possession and Cultivation of Cannabis Unconstitutional in 2018
Mexico‘s high court in April granted a second deadline extension to give legislators additional time to enact the policy change amid the coronavirus pandemic, pushing it to December 15. That said, Ricardo Monreal, the ruling MORENA party’s leader in the Senate, said the chamber will advance the bill before the end of October.
READ FULL MEXICO CANNABIS ARTICLE
Psychedelics is an Emerging Industry with a Lot of Potential in the Way of Drug Development and Therapy
Entheon Biomedical is comprised of a team of researchers who are dedicating their work to the treatment of substance abuse disorders. The company’s research centers around Psychedelic analogs and how these pharmaceutical compounds hold great potential in treating chronic addictions.
READ FULL PSYCHEDELICS FOR ADDICTION ARTICLE
In Spite of the Global Pandemic, Illinois Has Seen Record-Breaking Marijuana Sales Month-Over-Month, Contributing to the Significant Tax Revenue That’s Being Used to Fund Local Governments and Restorative Justice Programs
Illinois has hit a Marijuana tax milestone, the state announced on Tuesday, collecting more than $100 million in revenue from Cannabis sales since the recreational legalization program launched this year.
READ FULL ILLINOIS CANNABIS ARTICLE
Photo by Esteban Lopez on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!